1.Study of high-risk factors for cervical lymph node metastasis in papillary carcinoma of the thyroid isthmus
Ziyi CHEN ; Tian JIANG ; Chen CHEN ; Lingyan ZHOU
Chinese Journal of Ultrasonography 2025;34(11):976-982
Objective:To investigate the ultrasonographic features and risk factors of patients with papillary thyroid carcinoma(PTC)located in the isthmus of the thyroid gland combined with lymph node metastasis(LNM).Methods:A retrospective analysis was performed on a cohort of 614 patients diagnosed with isthmic PTC through postoperative pathological confirmation at Zhejiang Cancer Hospital between January 2020 and June 2024. The patients were divided into the LNM group( n=225)and non-LNM( n=389)based on the pathological results. The baseline information and ultrasound characteristics of the nodules were compared between the two groups. The risk factors associated with the development of LNM in patients with isthmus PTC were explored using univariate and multivariate Logistic regression analysis. The predictive performance was analyzed using ROC curve. Results:Comparison of the baseline information revealed that the age,maximum diameter of the cancerous lesion,gender were statistically different between LNM group and non-LNM group(all P<0.05). Comparison of thyroid nodule ultrasound characteristics showed that there were statistically significant differences in boundary,aspect ratio,calcification,and color Doppler blood flow imaging(CDFI)grades between the two groups(all P<0.05). Univariate and multifactorial Logistic regression analyses showed that the maximum diameter of the cancer foci( OR=1.180,95% CI=1.119-1.244),gender is female( OR=1.798,95% CI=1.187-2.723),and microcalcification( OR=1.509,95% CI=0.183-12.441)were the factors affecting LNM of the isthmus PTC. The AUC value of the model used to predict the occurrence of LNM in isthmus PTC was 0.756(95% CI=0.717 - 0.795),with a sensitivity of 75.8% and a specificity of 63.6%. Conclusions:The maximum diameter of the cancer foci,microcalcification and gender female were independent risk factors for the occurrence of LNM in patients with thyraid isthmus PTC. The model constructed based on the above characteristics has a better predictive performance for thyroid isthmus PTC with LNM,and patients with the above high-risk character istics should be more vigilant.
2.LocPro: A deep learning-based prediction of protein subcellular localization for promoting multi-directional pharmaceutical research.
Yintao ZHANG ; Lingyan ZHENG ; Nanxin YOU ; Wei HU ; Wanghao JIANG ; Mingkun LU ; Hangwei XU ; Haibin DAI ; Tingting FU ; Ying ZHOU
Journal of Pharmaceutical Analysis 2025;15(8):101255-101255
Drug development encompasses multiple processes, wherein protein subcellular localization is essential. It promotes target identification, treatment development, and the design of drug delivery systems. In this research, a deep learning framework called LocPro is presented for predicting protein subcellular localization. Specifically, LocPro is unique in (a) combining protein representations from the pre-trained large language model (LLM) ESM2 and the expert-driven tool PROFEAT, (b) implementing a hybrid deep neural network architecture that integrates convolutional neural network (CNN), fully connected (FC) layer, and bidirectional long short-term memory (BiLSTM) blocks, and (c) developing a multi-label framework for predicting protein subcellular localization at multiple granularity levels. Additionally, a dataset was curated and divided using a homology-based strategy for training and validation. Comparative analyses show that LocPro outperforms existing methods in sequence-based multi-label protein subcellular localization prediction. The practical utility of this framework is further demonstrated through case studies on drug target subcellular localization. All in all, LocPro serves as a valuable complement to existing protein localization prediction tools. The web server is freely accessible at https://idrblab.org/LocPro/.
3.LocPro:A deep learning-based prediction of protein subcellular localization for promoting multi-directional pharmaceutical research
Yintao ZHANG ; Lingyan ZHENG ; Nanxin YOU ; Wei HU ; Wanghao JIANG ; Mingkun LU ; Hangwei XU ; Haibin DAI ; Tingting FU ; Ying ZHOU
Journal of Pharmaceutical Analysis 2025;15(8):1765-1773
Drug development encompasses multiple processes,wherein protein subcellular localization is essential.It promotes target identification,treatment development,and the design of drug delivery systems.In this research,a deep learning framework called LocPro is presented for predicting protein subcellular localization.Specifically,LocPro is unique in(a)combining protein representations from the pre-trained large language model(LLM)ESM2 and the expert-driven tool PROFEAT,(b)implementing a hybrid deep neural network architecture that integrates convolutional neural network(CNN),fully connected(FC)layer,and bidirectional long short-term memory(BiLSTM)blocks,and(c)developing a multi-label framework for predicting protein subcellular localization at multiple granularity levels.Additionally,a dataset was curated and divided using a homology-based strategy for training and validation.Compar-ative analyses show that LocPro outperforms existing methods in sequence-based multi-label protein subcellular localization prediction.The practical utility of this framework is further demonstrated through case studies on drug target subcellular localization.All in all,LocPro serves as a valuable complement to existing protein localization prediction tools.The web server is freely accessible at https://idrblab.org/LocPro/.
4.Study of high-risk factors for cervical lymph node metastasis in papillary carcinoma of the thyroid isthmus
Ziyi CHEN ; Tian JIANG ; Chen CHEN ; Lingyan ZHOU
Chinese Journal of Ultrasonography 2025;34(11):976-982
Objective:To investigate the ultrasonographic features and risk factors of patients with papillary thyroid carcinoma(PTC)located in the isthmus of the thyroid gland combined with lymph node metastasis(LNM).Methods:A retrospective analysis was performed on a cohort of 614 patients diagnosed with isthmic PTC through postoperative pathological confirmation at Zhejiang Cancer Hospital between January 2020 and June 2024. The patients were divided into the LNM group( n=225)and non-LNM( n=389)based on the pathological results. The baseline information and ultrasound characteristics of the nodules were compared between the two groups. The risk factors associated with the development of LNM in patients with isthmus PTC were explored using univariate and multivariate Logistic regression analysis. The predictive performance was analyzed using ROC curve. Results:Comparison of the baseline information revealed that the age,maximum diameter of the cancerous lesion,gender were statistically different between LNM group and non-LNM group(all P<0.05). Comparison of thyroid nodule ultrasound characteristics showed that there were statistically significant differences in boundary,aspect ratio,calcification,and color Doppler blood flow imaging(CDFI)grades between the two groups(all P<0.05). Univariate and multifactorial Logistic regression analyses showed that the maximum diameter of the cancer foci( OR=1.180,95% CI=1.119-1.244),gender is female( OR=1.798,95% CI=1.187-2.723),and microcalcification( OR=1.509,95% CI=0.183-12.441)were the factors affecting LNM of the isthmus PTC. The AUC value of the model used to predict the occurrence of LNM in isthmus PTC was 0.756(95% CI=0.717 - 0.795),with a sensitivity of 75.8% and a specificity of 63.6%. Conclusions:The maximum diameter of the cancer foci,microcalcification and gender female were independent risk factors for the occurrence of LNM in patients with thyraid isthmus PTC. The model constructed based on the above characteristics has a better predictive performance for thyroid isthmus PTC with LNM,and patients with the above high-risk character istics should be more vigilant.
5.Implementation of teaching clinic in the standardized training of general practice residents: current situation and implications
Xinyan YU ; Lingyan WU ; Lingna MAO ; Ming NI ; Zhizhi JIANG ; Yuling TONG ; Yi GUO ; Zhenya SONG ; Zhijie XU
Chinese Journal of Medical Education Research 2024;23(9):1281-1285
Teaching clinics represent a unique form of outpatient training of resident physicians and serve as a crucial instrument and core component of standardized training of general practice residents. This article reviews the common model and innovations of teaching clinics of general practice in China, and analyzes their reported effectiveness in enhancing the capabilities of consultation of resident physicians, the teaching capabilities of general practice trainers, as well as satisfaction levels of involved participants. It outlines the challenges encountered in implementing teaching clinics, including inadequate teaching facilities and equipment, incomplete incentive system for teaching, difficulties in patient recruitment, and weaknesses in the teaching capabilities of trainers. To address these challenges, this article proposes corresponding strategies based on realistic needs, including the improvement of facilities and equipment in teaching clinics, the establishment of incentive systems for teaching clinics, the expansion of patient recruitment channels for teaching clinics, and the enhancement of training for trainers' teaching capabilities. This is envisaged to provide both theoretical bases and practical guidance for the effective execution and standardized development of teaching clinics in general practice residency training bases.
6.Effect of Qinghua Yichang Formula (清化益肠方) on NLRP3 Inflammasome in Intestinal Tissue of Mice with Acute Radiation-Induced Intestinal Injury
Yuanyuan QIN ; Lingyan ZHU ; Li LI ; Bowen CHU ; Zequn JIANG ; Mianhua WU
Journal of Traditional Chinese Medicine 2024;65(16):1695-1702
ObjectiveTo explore the effect and possible molecular mechanism of Qinghua Yichang Formula (清化益肠方, QYF) in treating acute radiation-induced intestinal injury mice via NOD-like receptor thermal protein domain associated protein 3 (NLRP3). MethodsSixty C57BL/6J mice were randomly divided into control group, model group, pre-modeling medication group, post-modeling medication group, inhibitor group, and QYF plus inhibitor group, with 10 mice in each group.Except for the control group, the other five groups were irradiated with a single full dose to establish the acute radiation-induced intestinal injury mice model. The pre-modeling medication group and the QYF plus inhibitor group were continuously given 4 g/ml of QYF decoction by gavage before modeling, 0.2 ml each time, once a day for 7 days. The post-modeling medication group, pre-modeling medication group and QYF plus inhibitor group were given 4 g/ml of QYF decoction for 14 days after modeling. The control group, model group and inhibitor group were given 0.2 ml of normal saline once a day for 14 consecutive days. Two hours after irradiation, the inhibitor group and the QYF plus inhibitor group were given an intraperitoneal injection of 0.2 ml of the NLRP3 inhibitor MCC950 (concentration: 10 mg/kg), once every two days. To observe the pathological changes in intestinal tissues, hematoxylin-eosin (HE) staining was used. Western blotting and RT-qPCR were used to detect the protein and mRNA expression levels of NLRP3 in intestinal tissues. Immunohistochemistry was used to detect the expression level of NLRP3, Caspase-1 and GSDMD in intestinal tissues. The proportion of CD4+ and CD8+ T cells in the spleens of mice were detected by flow cytometry. ELISA was used to determine the levels of IFN-γ, IL-18, and IL-1β in mice serum. ResultsHE staining showed no lesions in the intestinal tissue of mice in the control group. The mice in the model group had shortened intestinal villi, thinned mucosal layers, multifocal mucosal necrosis in the lamina propria, and local neutrophil infiltration. The pathological damage of intestinal tissue of mice in each medication group was improved to varied degrees, among which the QYF plus inhibitor group showed most obvious improvement. Compared to those in the control group, the protein and mRNA expression levels of NLRP3 in the intestinal tissue of mice in the model group significantly increased, with higher NLRP3, Caspase-1, and GSDMD protein expression in the intestinal tissue, increased proportion of CD4+ T cells in spleen, decreased proportion of CD8+ T cells, and increased levels of IFN-γ, IL-18 and IL-1β in serum (P<0.05). Compared to those in the model group, the above indicators in the other medication groups were all improved (P<0.05).The NLRP3, Caspase-1, and GSDMD proteins in the pre-modeling medication group were lower than those in the post-modeling medication group (P<0.05); and the NLRP3 mRNA level in the QYF plus inhibitor group was lower than that in the inhibitor group (P<0.05). ConclusionQYF may play a role in preventing and treating acute radiation-induced intestinal injury by inhibiting the expression of NLRP3.
7.Consensus on prescription review of commonly used H 1-antihistamines in pediatrics
Lihua HU ; Lu LIU ; Huiying CHEN ; Heping CAI ; Wentong GE ; Zhiying HAN ; Huijie HUANG ; Xing JI ; Yuntao JIA ; Lingyan JIAN ; Nannan JIANG ; Zhong LI ; Li LI ; Hua LIANG ; Chuanhe LIU ; Qinghong LU ; Xu LU ; Jun′e MA ; Jing MIAO ; Yanli REN ; Yunxiao SHANG ; Kunling SHEN ; Huajun SUN ; Jinqiao SUN ; Yanyan SUN ; Jianping TANG ; Hong WANG ; Lianglu WANG ; Xiaochuan WANG ; Lei XI ; Hua XU ; Zigang XU ; Meixing YAN ; Yong YIN ; Shengnan ZHANG ; Zhongping ZHANG ; Xin ZHAO ; Deyu ZHAO ; Wei ZHOU ; Li XIANG ; Xiaoling WANG
Chinese Journal of Applied Clinical Pediatrics 2023;38(10):733-739
H 1-antihistamines are widely used in the treatment of various allergic diseases, but there are still many challenges in the safe and rational use of H 1-antihistamines in pediatrics, and there is a lack of guidance on the prescription review of H 1-antihistamines for children.In this paper, suggestions are put forward from the indications, dosage, route of administration, pathophysiological characteristics of children with individual difference and drug interactions, so as to provide reference for clinicians and pharmacists.
8.Recommendations for prescription review of commonly used anti-seizure medications in treatment of children with epilepsy
Qianqian QIN ; Qian DING ; Xiaoling LIU ; Heping CAI ; Zebin CHEN ; Lina HAO ; Liang HUANG ; Yuntao JIA ; Lingyan JIAN ; Zhong LI ; Hua LIANG ; Maochang LIU ; Qinghong LU ; Xiaolan MO ; Jing MIAO ; Yanli REN ; Huajun SUN ; Yanyan SUN ; Jing XU ; Meixing YAN ; Li YANG ; Shengnan ZHANG ; Shunguo ZHANG ; Xin ZHAO ; Jie DENG ; Fang FANG ; Li GAO ; Hong HAN ; Shaoping HUANG ; Li JIANG ; Baomin LI ; Jianmin LIANG ; Jianxiang LIAO ; Zhisheng LIU ; Rong LUO ; Jing PENG ; Dan SUN ; Hua WANG ; Ye WU ; Jian YANG ; Yuqin ZHANG ; Jianmin ZHONG ; Shuizhen ZHOU ; Liping ZOU ; Yuwu JIANG ; Xiaoling WANG
Chinese Journal of Applied Clinical Pediatrics 2023;38(10):740-748
Anti-seizure medications (ASMs) are the main therapy for epilepsy.There are many kinds of ASMs with complex mechanism of action, so it is difficult for pharmacists to examine prescriptions.This paper put forward some suggestions on the indications, dosage forms/routes of administration, appropriateness of usage and dosage, combined medication and drug interaction, long-term prescription review, individual differences in pathophysiology of children, and drug selection when complicated with common epilepsy, for the reference of doctors and pharmacists.
9.Advantages of Traditional Chinese Medicine in Treating Dominant Disease: Allergic Rhinitis
Lili LIU ; Daxin LIU ; Jinfeng LIU ; Shuzhen GUO ; Zhonghai XIN ; Renzhong WANG ; Li TIAN ; Kuiji WANG ; Mingxia ZHANG ; Shirui YANG ; Shufan GUO ; Yonggang LIU ; Wei ZHANG ; Lingyan JIANG ; Hui CHEN ; Xing LIAO ; Geng LI ; Chenyu CHI ; Xiaoxiao ZHANG ; Zhanfeng YAN
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(2):203-211
In response to the Opinions of the CPC Central Committee and the State Council on Promoting the Inheritance, Innovation, and Development of traditional Chinese medicine(TCM) and the spirit of the National Conference on TCM, Chinese Association of Chinese Medicine organized experts in Otorhinolaryngology Head and Neck Surgery of traditional Chinese and western medicine to discuss the clinical advantages of TCM and integrated traditional Chinese and western medicine in the treatment of allergic rhinitis (AR) and they reached a basic consensus. In recent years, the prevalence of AR has been on the rise, threatening the quality of life of patients and giving rise to a heavy burden to both the patients and the society. AR is resulted from immune imbalance rather than reduced immunity or hyperimmunity, and the imbalance is similar to the Yin-yang disharmony in TCM. In the treatment of this disease, western medicine features rapid onset. However, it is cost-intensive and causes severe surgical trauma, and the recurrence is common. TCM boasts diverse methods for AR, which can be used in all stages of this disease. It has advantages in controlling symptoms such as nasal congestion, runny nose, or dysosmia in the attack stage, preventing recurrence in the remission stage, and treating refractory AR or steroid-resistant AR. In particular, acupuncture enjoys a reputation in treatment of AR, which has been supported by evidence-based medicine and recommended by guidelines. While treating local symptoms of AR, TCM regulates the psychosomatic conditions, which facilitates chronic disease management and long-term follow-up. We should integrate the advantages of TCM and western medicine, give full play to the unique nonnegligible and irreplaceable advantages of TCM, formulate a comprehensive diagnosis and treatment scheme for learning and promotion, and summarize the research outcomes to promote the theoretical innovation of TCM on AR from the perspective of integrated traditional Chinese and western medicine.
10.The osteogenesis of Ginsenoside Rb1 incorporated silk/micro-nano hydroxyapatite/sodium alginate composite scaffolds for calvarial defect.
Yuqiong WU ; Jiahui DU ; Qianju WU ; Ao ZHENG ; Lingyan CAO ; Xinquan JIANG
International Journal of Oral Science 2022;14(1):10-10
Ginsenoside Rb1, the effective constituent of ginseng, has been demonstrated to play favorable roles in improving the immunity system. However, there is little study on the osteogenesis and angiogenesis effect of Ginsenoside Rb1. Moreover, how to establish a delivery system of Ginsenoside Rb1 and its repairment ability in bone defect remains elusive. In this study, the role of Ginsenoside Rb1 in cell viability, proliferation, apoptosis, osteogenic genes expression, ALP activity of rat BMSCs were evaluated firstly. Then, micro-nano HAp granules combined with silk were prepared to establish a delivery system of Ginsenoside Rb1, and the osteogenic and angiogenic effect of Ginsenoside Rb1 loaded on micro-nano HAp/silk in rat calvarial defect models were assessed by sequential fluorescence labeling, and histology analysis, respectively. It revealed that Ginsenoside Rb1 could maintain cell viability, significantly increased ALP activity, osteogenic and angiogenic genes expression. Meanwhile, micro-nano HAp granules combined with silk were fabricated smoothly and were a delivery carrier for Ginsenoside Rb1. Significantly, Ginsenoside Rb1 loaded on micro-nano HAp/silk could facilitate osteogenesis and angiogenesis. All the outcomes hint that Ginsenoside Rb1 could reinforce the osteogenesis differentiation and angiogenesis factor's expression of BMSCs. Moreover, micro-nano HAp combined with silk could act as a carrier for Ginsenoside Rb1 to repair bone defect.
Alginates/pharmacology*
;
Animals
;
Bone Regeneration
;
Cell Differentiation
;
Durapatite/pharmacology*
;
Ginsenosides
;
Osteogenesis
;
Rats
;
Silk/pharmacology*
;
Tissue Scaffolds

Result Analysis
Print
Save
E-mail